Living Donors Online Message Board
Living Donation Discussion and News => Living Donation in the News => Topic started by: Clark on January 31, 2017, 09:08:09 PM
-
http://onlinelibrary.wiley.com/doi/10.1111/ajt.14011/abstract?campaign=wolacceptedarticle (http://onlinelibrary.wiley.com/doi/10.1111/ajt.14011/abstract?campaign=wolacceptedarticle)
Minireview
Long-Term Non–End-Stage Renal Disease Risks After Living Kidney Donation
A. J. Matas, R. E. Hays, H. N. Ibrahim
DOI: 10.1111/ajt.14011
American Journal of Transplantation
Abstract
Despite generally positive outcomes and high rates of satisfaction, living kidney donors are at risk for both medical and psychosocial problems. In this review, the authors summarize non–end-stage renal disease (ESRD) risks for donors and describe limitations to the data. We review the evidence of medical risks (e.g. increased cardiovascular disease and mortality, preeclampsia) and psychosocial risks (e.g. mood disturbance, financial burden). We then discuss the evidence of differential risks among subsets and the impact of postdonation events (e.g. development of diabetes). Collectively, available evidence indicates the following.
- Recognizing the importance of non-ESRD risks has been overshadowed by analyses of the reported risk of ESRD. This imbalance should be remedied. There is little quantification of the true contribution of donation to medical and psychosocial outcomes. Most studies, to date, have been retrospective, with limited sample sizes and diversity and with less-than-ideal controls for comparison of outcomes. Many postdonation events (diabetes and hypertension) can now be reasonably predicted, and their association with adverse outcomes can be quantified. Mechanisms and systems need to be implemented to evaluate and care for donors who develop medical and/or psychosocial problems. Costs to donors are a significant burden, and making donation financially neutral should be a priority.